HARVARD BIOSCIENCE INC Net Income Loss

Quick Answer

HARVARD BIOSCIENCE INC reported Net Income Loss of -$56.70 million for the year ending 2025.

  • HARVARD BIOSCIENCE INC showed a decrease of -357.1% in Net Income Loss from 2024 to 2025.
  • This data is from HARVARD BIOSCIENCE INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
  • XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: -$186.0 thousand | Q3 2013: -$984.0 thousand | Q4 2013: -$756.0 thousand | Q1 2014: $719.0 thousand | Q2 2014: $1.02 million | Q3 2014: $633.0 thousand | Q4 2014: -$19.0 thousand | Q1 2015: -$1.40 million | Q2 2015: $349.0 thousand | Q3 2015: -$847.0 thousand | Q4 2015: -$17.14 million | Q1 2016: -$636.0 thousand | Q2 2016: -$713.0 thousand | Q3 2016: -$1.64 million | Q4 2016: -$1.32 million | Q1 2017: -$1.07 million | Q2 2017: -$381.0 thousand | Q3 2017: -$417.0 thousand | Q4 2017: $999.0 thousand | Q1 2018: -$4.06 million | Q2 2018: -$1.46 million | Q3 2018: -$256.0 thousand | Q4 2018: $2.86 million | Q1 2019: -$2.37 million | Q2 2019: -$247.0 thousand | Q3 2019: -$2.62 million | Q4 2019: $550.0 thousand | Q1 2020: -$4.52 million | Q2 2020: -$1.58 million | Q3 2020: -$1.10 million | Q1 2021: -$669.0 thousand | Q2 2021: -$410.0 thousand | Q3 2021: -$170.0 thousand | Q1 2022: -$6.88 million | Q2 2022: $2.44 million | Q3 2022: -$3.41 million | Q1 2023: $622.0 thousand | Q2 2023: -$980.0 thousand | Q3 2023: -$1.24 million | Q1 2024: -$4.69 million | Q2 2024: -$2.93 million | Q3 2024: -$4.80 million | Q1 2025: -$50.34 million | Q2 2025: -$2.28 million | Q3 2025: -$1.23 million.
  • Over the full 17 years of available data (2009 to 2025), HARVARD BIOSCIENCE INC's Net Income Loss has declined by 883.9%.
  • Historical annual values: Fiscal year 2025: -$56.70 million | Fiscal year 2024: -$12.41 million | Fiscal year 2023: -$3.42 million | Fiscal year 2022: -$9.52 million | Fiscal year 2021: -$288.0 thousand | Fiscal year 2020: -$7.81 million | Fiscal year 2019: -$4.69 million | Fiscal year 2018: -$2.92 million | Fiscal year 2017: -$865.0 thousand | Fiscal year 2016: -$4.31 million | Fiscal year 2015: -$19.04 million | Fiscal year 2014: $2.36 million | Fiscal year 2013: -$1.83 million | Fiscal year 2012: $2.37 million | Fiscal year 2011: $3.81 million | Fiscal year 2010: $19.02 million | Fiscal year 2009: $7.23 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: